Literature DB >> 25436197

Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method.

Mohammad Reza Siahi-Shadbad1, Saeed Ghanbarzadeh2, Mohammad Barzegar-Jalali1, Hadi Valizadeh3, Alireza Taherpoor3, Ghobad Mohammadi4, Azim Barzegar-Jalali5, Khosro Adibkia6.   

Abstract

PURPOSE: The purpose of this study was to prepare and characterize solid dispersion formulation of furosemide to enhance dissolution rate.
METHODS: Solid dispersions with different drug: carrier ratios were prepared by cogrinding method using crospovidone and microcrystalline cellulose as carrier. The physical state and interactions between the drug and carrier were characterized by Fourier transform infrared spectroscopic (FT-IR) and X ray diffraction (XRD).
RESULTS: Solid dispersions (especially with drug: Carrier ratio of 1:2) showed a higher dissolution rate than their respective physical mixture and pure furosemide. Dissolution rate in pH 5.8 was also higher than pH 1.2. The XRD analysis showed that crystalline form was changed to the amorphous state in the solid dispersions. FT-IR analysis did not show any physicochemical interactions in the solid dispersion formulations. Release kinetic of formulations were fitted best to the Weibull and Wagner log probability (linear kinetic) as well as suggested 2 and Gompertz (non-linear kinetic) models.
CONCLUSION: The dissolution properties of furosemide were improved with the use of hydrophilic carriers in solid dispersions due to change in the crystalline form of the drug and more intimate contact between drug and carriers which was dependent on the type and ratio of carrier as well as dissolution medium pH.

Entities:  

Keywords:  Dissolution rate; Furosemide; Release kinetic; Solid dispersion

Year:  2014        PMID: 25436197      PMCID: PMC4137431          DOI: 10.5681/apb.2014.058

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  27 in total

1.  Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.

Authors:  Songming Li; Ying Liu; Tao Liu; Ling Zhao; Jihui Zhao; Nianping Feng
Journal:  Int J Pharm       Date:  2011-04-12       Impact factor: 5.875

2.  Co-solubilization of poorly soluble drugs by micellization and complexation.

Authors:  Venkatramana M Rao; M Nerurkar; S Pinnamaneni; F Rinaldi; K Raghavan
Journal:  Int J Pharm       Date:  2006-04-07       Impact factor: 5.875

3.  Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs.

Authors:  Guy Van den Mooter; Ilse Weuts; Thomas De Ridder; Norbert Blaton
Journal:  Int J Pharm       Date:  2006-03-06       Impact factor: 5.875

Review 4.  Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.

Authors:  Chau Le-Ngoc Vo; Chulhun Park; Beom-Jin Lee
Journal:  Eur J Pharm Biopharm       Date:  2013-09-18       Impact factor: 5.571

5.  Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.

Authors:  Nicola De Zordi; Mariarosa Moneghini; Ireneo Kikic; Mario Grassi; Antonio Esau Del Rio Castillo; Dario Solinas; Michael B Bolger
Journal:  Eur J Pharm Biopharm       Date:  2012-01-17       Impact factor: 5.571

6.  Ibuprofen-phospholipid solid dispersions: improved dissolution and gastric tolerance.

Authors:  M Delwar Hussain; Vipin Saxena; James F Brausch; Rahmat M Talukder
Journal:  Int J Pharm       Date:  2011-11-15       Impact factor: 5.875

7.  To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.

Authors:  Hiba Al-Hamidi; Alison A Edwards; Mohammad A Mohammad; Ali Nokhodchi
Journal:  Colloids Surf B Biointerfaces       Date:  2009-11-11       Impact factor: 5.268

8.  Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.

Authors:  C Goddeeris; T Willems; K Houthoofd; J A Martens; G Van den Mooter
Journal:  Eur J Pharm Biopharm       Date:  2008-07-22       Impact factor: 5.571

9.  Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.

Authors:  Hajime Konno; Tetsurou Handa; David E Alonzo; Lynne S Taylor
Journal:  Eur J Pharm Biopharm       Date:  2008-06-06       Impact factor: 5.571

10.  Physicochemical characterization of solid dispersion of furosemide with TPGS.

Authors:  Sang-Chul Shin; Jin Kim
Journal:  Int J Pharm       Date:  2003-01-30       Impact factor: 5.875

View more
  2 in total

1.  Characterization and Bioavailability of Wogonin by Different Administration Routes in Beagles.

Authors:  Na Zhu; Jian-Chun Li; Jin-Xiu Zhu; Xiu Wang; Jin Zhang
Journal:  Med Sci Monit       Date:  2016-10-16

2.  Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.

Authors:  Viviana De Caro; Alessia Ajovalasit; Flavia Maria Sutera; Denise Murgia; Maria Antonietta Sabatino; Clelia Dispenza
Journal:  Pharmaceutics       Date:  2017-06-24       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.